Thursday, July 9, 2026

pharma · HER2-positive · CARM

Carisma Therapeutics

Carisma Therapeutics patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Philadelphia, USA HQ
2016 Founded
15 Employees
Public company Type
CARM · NYSE Ticker
Company details
Status
Public
HQ
Philadelphia, USA
Founded
2016
Employees
15
Programs
2
Drugs
1
Patents
2
Intelligence · Patents

Carisma Therapeutics patents

2 pharmaceutical patents indexed for Carisma Therapeutics. 0 expire within 24 months.

Carisma Therapeutics has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11739297

    Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11312939

    Constructs for chimeric antigen receptors

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Carisma Therapeutics have?

2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Carisma Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.